For more than 20 years, Alex has been working with Canada’s health technology assessment systems, both from the public and private sector. Before joining the pharmaceutical industry in 2019, Alex was the Director of CDA’s pan-Canada Oncology Drug Review (pCODR) program. Prior to that she was a Clinical Epidemiologist with Health Quality Ontario and the Ontario Health Technology Advisory Committee (OHTAC).
Day 1 Oct 28, 2025
12:10 pm
INDUSTRY EXPERT
The Role of Private Payers in Canada’s Market Access Landscape
Private payers play a crucial role in ensuring Canadians have access to innovative treatments. By bridging the gap between public coverage and out-of-pocket expenses, private insurers help patients receive timely and comprehensive healthcare solutions. Master the success factors to:
- Understand how private payers enhance access to treatment for patients.
- Explore how private payers can collaborate with pharmaceutical companies, healthcare providers, and employers to develop sustainable reimbursement models.
- Examine the role of innovative drug coverage programs, value-based agreements, and digital health solutions in improving patient outcomes.
Heighten collaboration between private payers and healthcare stakeholders to optimize patient access and treatment outcomes.
Day 2 Oct 29, 2025
